Aldeyra Therapeutics, Inc. news

Investor announcements, newest first.

Close
Company news
Aldeyra Therapeutics, Inc.
Dec 19, 2023 at 5:00 AM UTC
Dec 19
Dec 19, 2023 at 5:00 AM UTC
Original

Aldeyra Therapeutics Announces Statistically and Clinically Significant Improvement from Baseline in Phase 2 Clinical Trial of ADX‑629 in Patients with Atopic Dermatitis

  • Statistically significant improvement from baseline observed in investigator-assessed Eczema Area and Severity Index (EASI, p=0.0006) and Investigator Global Assessment (IGA, p